证券记录 · 已归档季度
MDT
Medtronic plc · Healthcare · Medical - Devices
21被追踪持有人
+1Δ持有人
104.49M持有股份
$9.40B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.0% ·
股份流向 +7.2% ·
净新建仓位 +4.8%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.44M | $115.59M | n/a | −2 |
| Q2 2026 | 172 | +1 | 851.51M | $67.87B | +6 | −7 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | n/a |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | n/a | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | n/a |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | n/a | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | n/a |
| Q2 2024 | 20 | n/a | 97.49M | $7.67B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 26.48M | -1.4% | $2.38B | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 18.40M | -13.4% | $1.66B | 0.3% | ▼ Trim | 2 | SEC ↗ ×7 |
| 3 | Norges Bank ✦ (被动) | 14.50M | -6.9% | $1.31B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 6.94M | -0.7% | $624.45M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | Dodge & Cox ✦ | 6.76M | -0.4% | $608.92M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 6 | Millennium Management ✦ | 6.22M | +212.6% | $559.76M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 5.89M | +11.5% | $530.61M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 5.82M | +453.4% | $524.08M | 0.6% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Arrowstreet Capital ✦ | 3.52M | -25.7% | $317.28M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 2.14M | +48.2% | $191.34M | 0.3% | ▲ Add | 2 | SEC ↗ ×5 |
| 11 | Adage Capital Partners ✦ | 1.54M | +40.5% | $139.00M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.36M | +348.1% | $122.03M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 1.31M | +106.3% | $118.18M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 921.70K | 新增 | $82.98M | 0.3% | New | 1 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 864.95K | -0.6% | $77.87M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 582.73K | -57.7% | $52.46M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 532.30K | +23.1% | $47.92M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 18 | D. E. Shaw & Co. ✦ | 353.77K | +85.9% | $31.85M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 19 | Gotham Asset Management ✦ | 237.84K | -30.2% | $21.41M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 107.25K | -60.0% | $9.66M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 21 | GAMCO Investors ✦ | 3.34K | -14.8% | $300,880 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $82.98M | 0.3% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 2,204 持有人, 1.04B 股份, $87.65B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
Marinaro Michael
Officer · 10.42K 股 · $1.00M
Oct 15
Martha Geoffrey
Officer, Director · 50.00K 股 · $4.75M
Sep 16
KIIL HARRY SKIP
Officer · 1.48K 股 · $138,883
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据